FBI search of his office fails to rattle Bristol-Myers CEO

07/29/2006 | NYTimes.com

In the wake of an FBI search of his office over a possibly criminal deal with other drugmakers, Bristol-Myers Squibb CEO Peter Dolan maintains his aplomb. The criminal inquiry is into a deal reached by Bristol and marketing partner Sanofi-Aventis with Apotex to settle its patent suit over the Plavix blood-thinner, now rejected by 56 attorneys general.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care